-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Maintains Buy on Compass Pathways, Raises Price Target to $20

Benzinga·05/15/2026 19:52:23
Listen to the news
Maxim Group analyst Jason McCarthy maintains Compass Pathways (NASDAQ:CMPS) with a Buy and raises the price target from $12 to $20.